What is FitLife Brands' operating income?

FitLife Brands' total operating income in 2025 was $10.06 million, based on the following breakdown: Total Gross Profit: $31.45 million Total Operating Expenses: $21.39 million

FitLife Brands (FTLF) Financials

$11.19 -0.02 (-0.18%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$11.11 -0.08 (-0.71%)

As of 07/13/2026 06:18 PM Eastern

Compare

Annual Income Statements for FitLife Brands

This table shows FitLife Brands' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	1.67	-1.08	0.37	-9.76	5.09	8.83	5.41	4.43	5.30	8.98	6.33
Consolidated Net Income / (Loss)	1.67	-1.08	0.37	-9.76	5.22	8.83	5.41	4.43	5.30	8.98	6.33
Net Income / (Loss) Continuing Operations	1.59	-1.09	0.37	-9.76	5.22	8.83	5.41	4.43	5.30	8.98	6.33
Total Pre-Tax Income	1.76	-1.09	0.37	-9.07	5.23	4.41	6.71	5.82	7.00	12	8.23
Total Operating Income	1.85	-1.09	0.47	-8.95	4.99	4.35	6.23	5.70	7.55	13	10
Total Gross Profit	7.09	6.28	10	5.09	16	9.54	13	12	21	28	31
Total Revenue	20	18	25	18	38	22	28	29	53	64	81
Operating Revenue	20	18	25	18	38	22	28	29	53	64	81
Total Cost of Revenue	13	12	15	13	22	13	15	17	31	36	50
Operating Cost of Revenue	13	12	15	13	22	13	15	17	31	36	50
Total Operating Expenses	5.24	7.37	9.60	14	11	5.19	6.27	6.33	14	15	21
Selling, General & Admin Expense	2.64	4.14	5.00	4.19	6.10	3.05	6.22	6.01	7.89	9.97	14
Marketing Expense	2.38	2.93	4.12	3.53	4.77	2.11	-	-	4.28	4.63	4.86
Depreciation Expense	0.23	0.30	0.48	0.41	0.10	0.04	0.06	0.07	0.09	0.11	0.42
Restructuring Charge	-	-	-	-	-	-	-	0.26	1.63	0.26	2.08
Total Other Income / (Expense), net	-0.09	0.00	-0.10	-0.11	0.25	0.07	0.48	0.12	-0.55	-1.25	-1.83
Interest Expense	0.09	-	0.11	-0.11	0.09	0.00	-0.48	0.00	1.03	1.37	1.86
Interest & Investment Income	-	-	-	-	0.00	-	-	0.12	0.29	0.07	0.10
Other Income / (Expense), net	-	-	0.01	-	0.34	0.07	-	0.00	0.19	0.05	-0.07
Income Tax Expense	0.17	0.00	0.00	0.69	0.01	-4.42	1.30	1.39	1.71	2.89	1.90
Basic Earnings per Share	$0.20	($0.13)	$0.04	($0.93)	$4.96	$2.08	$1.23	$0.97	$0.59	$0.98	$0.68
Weighted Average Basic Shares Outstanding	8.18M	8.68M	10.34M	10.52M	2.05M	4.23M	4.41M	4.55M	8.98M	9.20M	9.35M
Diluted Earnings per Share	$0.20	($0.13)	$0.04	($0.93)	$4.66	$1.94	$1.13	$0.89	$0.54	$0.91	$0.63
Weighted Average Diluted Shares Outstanding	8.58M	8.68M	10.34M	10.52M	2.18M	4.55M	4.80M	4.98M	9.81M	9.90M	9.98M
Weighted Average Basic & Diluted Shares Outstanding	8.20M	-	-	-	-	1.09M	-	4.45M	4.60M	9.22M	9.39M

This table shows FitLife Brands' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	1.70	1.48	2.16	2.63	2.13	2.07	2.02	1.75	0.92	1.64	1.72
Consolidated Net Income / (Loss)	1.70	1.48	2.16	2.63	2.13	2.07	2.02	1.75	0.92	1.64	1.72
Net Income / (Loss) Continuing Operations	1.70	1.48	2.16	2.63	2.13	2.07	2.02	1.75	0.92	1.64	1.72
Total Pre-Tax Income	2.13	1.70	2.97	3.36	2.90	2.65	2.72	2.38	1.75	1.38	2.35
Total Operating Income	2.47	1.82	3.38	3.68	3.18	2.88	2.96	2.52	2.32	2.27	3.06
Total Gross Profit	5.70	5.36	7.29	7.58	7.00	6.21	6.87	6.90	8.74	8.94	9.52
Total Revenue	14	13	17	17	16	15	16	16	23	26	25
Operating Revenue	14	13	17	17	16	15	16	16	23	26	25
Total Cost of Revenue	8.21	7.94	9.26	9.35	8.98	8.80	9.06	9.22	15	17	16
Operating Cost of Revenue	8.21	7.94	9.26	9.35	8.98	8.80	9.06	9.22	15	17	16
Total Operating Expenses	3.23	3.54	3.91	3.88	3.82	3.33	3.92	4.39	6.42	6.67	6.46
Selling, General & Admin Expense	1.90	1.86	2.51	2.53	2.65	1.06	2.51	2.49	4.11	4.93	4.96
Marketing Expense	1.28	-	1.23	1.33	1.09	-	1.05	1.19	1.36	1.26	1.25
Depreciation Expense	0.02	0.03	0.04	0.03	0.02	0.02	0.02	0.01	0.14	0.25	0.25
Total Other Income / (Expense), net	-0.34	-0.13	-0.41	-0.32	-0.29	-0.23	-0.24	-0.14	-0.57	-0.89	-0.71
Interest Expense	0.25	0.43	0.41	0.35	0.33	0.28	0.24	0.23	0.58	0.81	0.74
Other Income / (Expense), net	-0.21	0.28	-0.01	0.01	0.02	0.02	-0.02	0.04	-0.01	-0.08	0.02
Income Tax Expense	0.43	0.22	0.81	0.73	0.77	0.58	0.70	0.63	0.83	-0.26	0.63
Basic Earnings per Share	$0.38	$0.16	$0.23	$0.29	$0.23	$0.23	$0.22	$0.19	$0.10	$0.18	$0.18
Weighted Average Basic Shares Outstanding	4.45M	8.98M	9.20M	9.20M	9.20M	9.20M	9.21M	9.39M	9.39M	9.35M	9.39M
Diluted Earnings per Share	$0.35	$0.16	$0.21	$0.27	$0.21	$0.23	$0.20	$0.18	$0.09	$0.18	$0.17
Weighted Average Diluted Shares Outstanding	4.89M	9.81M	10.06M	9.90M	9.93M	9.90M	9.93M	9.96M	10.00M	9.98M	9.99M
Weighted Average Basic & Diluted Shares Outstanding	4.59M	4.60M	4.60M	4.60M	4.60M	9.22M	9.39M	9.39M	9.39M	9.39M	9.39M

This table details how cash moves in and out of FitLife Brands' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	1.05	-3.53	-0.24	-0.03	0.01	6.07	3.56	3.38	-11	2.62	-2.87
Net Cash From Operating Activities	1.51	-2.46	0.05	0.67	2.26	5.72	4.48	4.13	4.22	9.61	7.44
Net Cash From Continuing Operating Activities	1.39	0.93	-2.67	6.36	2.26	5.72	4.48	4.13	4.21	9.52	7.44
Net Income / (Loss) Continuing Operations	1.67	-1.17	0.37	0.51	2.61	8.83	5.41	4.43	5.30	8.98	6.33
Consolidated Net Income / (Loss)	1.67	-1.17	0.37	0.51	2.61	8.83	5.41	4.43	5.30	8.98	6.33
Depreciation Expense	0.23	0.30	0.48	0.41	0.05	0.04	0.06	0.07	0.09	0.11	0.42
Amortization Expense	-	-	-	-	-0.00	0.00	0.05	0.06	0.41	0.04	1.09
Non-Cash Adjustments To Reconcile Net Income	-0.14	-0.25	0.29	6.04	0.01	0.12	0.24	0.31	0.40	0.31	0.55
Changes in Operating Assets and Liabilities, net	-0.40	-1.34	-1.09	3.98	-0.41	-3.26	-1.28	-0.73	-1.99	0.08	-0.95
Net Cash From Investing Activities	0.05	-0.41	-0.02	-0.19	0.00	0.00	-0.53	0.00	-36	-0.01	-43
Net Cash From Continuing Investing Activities	0.08	-0.41	-0.02	-0.19	0.00	0.00	-0.53	0.00	-36	-0.01	-43
Purchase of Property, Plant & Equipment	-0.00	-0.01	-0.02	-0.19	-	-	-	0.00	-0.11	-0.01	-43
Net Cash From Financing Activities	-0.50	-0.66	-0.26	-0.51	-2.26	0.35	-0.39	-0.75	20	-6.98	32
Net Cash From Continuing Financing Activities	-0.49	-0.66	-0.26	-0.51	-2.26	0.35	-0.39	-0.75	20	-6.98	32
Repayment of Debt	-0.49	-0.66	-0.57	-0.51	-0.80	-	-	0.00	-2.38	-7.00	-3.77
Issuance of Debt	-	0.00	0.46	0.00	0.30	0.45	-	0.00	23	0.00	46
Other Financing Activities, net	-	-	-	-	0.00	0.07	0.05	0.03	0.17	0.02	-10
Cash Interest Paid	0.09	0.09	0.11	0.11	0.05	0.01	-	0.00	0.78	1.36	1.75
Cash Income Taxes Paid	-	-	-	-	-	0.00	-0.04	0.00	0.70	2.50	2.36

This table details how cash moves in and out of FitLife Brands' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-1.52	-6.41	1.39	0.45	0.99	-0.20	1.47	-4.41	1.60	-1.54	-0.45
Net Cash From Operating Activities	0.98	1.45	5.04	1.57	2.05	0.96	2.33	1.20	3.67	0.24	2.48
Net Cash From Continuing Operating Activities	0.98	1.44	5.02	1.57	2.07	0.95	2.33	1.19	3.69	0.24	2.48
Net Income / (Loss) Continuing Operations	1.70	1.48	2.16	2.63	2.13	2.07	2.02	1.75	0.92	1.64	1.72
Consolidated Net Income / (Loss)	1.70	1.48	2.16	2.63	2.13	2.07	2.02	1.75	0.92	1.64	1.72
Depreciation Expense	0.02	0.03	0.04	0.03	0.02	0.02	0.02	0.01	0.14	0.25	0.25
Amortization Expense	0.02	0.35	0.01	0.04	0.06	0.02	0.04	0.02	0.38	0.66	0.11
Non-Cash Adjustments To Reconcile Net Income	0.02	0.35	0.05	-0.03	0.17	0.12	0.08	0.03	0.23	0.22	-0.34
Changes in Operating Assets and Liabilities, net	-0.78	-0.77	2.76	-1.09	-0.31	-1.29	0.17	-0.62	2.03	-2.53	0.75
Net Cash From Investing Activities	-1.83	-17	-0.01	-	-	-	-0.02	-5.01	-38	-0.01	0.00
Net Cash From Continuing Investing Activities	-1.83	-17	-0.01	-	-	-	-0.02	-5.01	-38	-0.01	0.00
Purchase of Property, Plant & Equipment	-0.01	-0.05	-0.01	-	-	-	-0.02	-5.01	-38	-0.01	0.00
Net Cash From Financing Activities	-0.63	9.05	-3.63	-1.13	-1.13	-1.11	-0.87	-0.70	36	-1.92	-2.92
Net Cash From Continuing Financing Activities	-0.63	9.05	-3.63	-1.13	-1.13	-1.11	-0.87	-0.70	36	-1.92	-2.92
Repayment of Debt	-0.63	-1.13	-3.63	-1.13	-1.13	-1.13	-1.13	-1.13	-	-1.52	-2.92
Other Financing Activities, net	-	-	0.00	-	-	-	0.26	0.42	-11	-	0.00
Effect of Exchange Rate Changes	-0.04	0.10	-	-	0.06	-0.05	0.04	0.10	-	-	-0.01
Cash Interest Paid	0.26	0.30	0.42	0.34	0.32	0.28	0.24	0.22	0.63	0.66	0.74
Cash Income Taxes Paid	0.35	0.11	0.17	0.35	0.59	1.39	0.41	1.53	0.34	0.08	0.43

This table presents FitLife Brands' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	10	18	15	6.86	6.04	17	22	26	55	59	106
Total Current Assets	8.37	9.54	7.93	6.32	5.41	12	18	23	15	18	33
Cash & Equivalents	4.35	1.53	1.29	1.26	0.27	6.34	9.90	13	1.14	4.47	1.65
Accounts Receivable	1.69	2.68	2.63	1.96	1.72	1.80	0.95	0.71	2.05	1.63	8.77
Inventories, net	2.28	4.79	3.76	2.87	3.36	3.53	6.52	9.11	9.09	11	21
Prepaid Expenses	0.05	0.33	0.14	0.22	0.07	0.05	0.32	0.12	0.64	0.92	1.33
Plant, Property, & Equipment, net	0.00	0.23	0.17	0.30	0.14	0.10	0.07	0.05	0.14	0.08	0.13
Total Noncurrent Assets	1.73	7.82	7.27	0.25	0.49	4.77	3.75	2.46	41	40	73
Goodwill	-	-	-	0.23	0.23	0.23	0.36	0.36	13	13	19
Intangible Assets	1.04	6.93	6.51	-	0.00	0.00	0.19	0.15	26	26	51
Noncurrent Deferred & Refundable Income Taxes	0.69	0.81	0.69	-	0.00	4.34	3.05	1.85	0.79	0.64	1.53
Other Noncurrent Operating Assets	0.00	0.03	0.02	0.02	0.26	0.21	0.16	0.10	0.12	0.41	0.77
Total Liabilities & Shareholders' Equity	10	18	15	6.86	6.04	17	22	26	55	59	106
Total Liabilities	3.39	7.45	4.85	5.95	2.97	4.75	4.16	4.32	28	22	63
Total Current Liabilities	1.95	6.53	4.48	5.95	2.76	4.14	4.06	4.27	10	11	22
Short-Term Debt	0.51	0.58	0.56	0.42	0.00	-	-	0.00	4.50	4.50	6.09
Accounts Payable	0.81	3.36	1.60	2.97	2.02	3.25	2.88	3.00	3.26	4.07	6.91
Accrued Expenses	-	-	-	-	0.46	0.50	0.49	0.44	1.03	0.68	5.43
Customer Deposits	-	-	-	-	0.23	0.35	0.63	0.59	0.57	0.56	1.04
Current Deferred & Payable Income Tax Liabilities	0.04	0.00	0.00	-	-	-	-	0.19	0.89	1.42	1.70
Other Current Liabilities	0.59	2.59	2.32	2.56	0.05	0.05	0.06	0.05	0.09	0.08	0.43
Total Noncurrent Liabilities	1.44	0.91	0.37	0.00	0.21	0.61	0.10	0.05	18	11	41
Long-Term Debt	1.44	0.91	0.37	-	0.00	0.45	-	0.00	16	8.55	38
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	-	-	-	0.00	2.41	2.21	2.32
Other Noncurrent Operating Liabilities	-	-	-	-	0.21	0.16	0.10	0.05	0.05	0.33	0.30
Total Equity & Noncontrolling Interests	6.71	10	11	0.91	3.07	12	17	21	27	36	44
Total Preferred & Common Equity	6.71	10	11	0.91	3.07	12	17	21	27	36	44
Preferred Stock	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	6.71	10	11	0.91	3.07	12	17	21	27	36	44
Common Stock	26	31	31	31	32	32	33	30	31	31	32
Retained Earnings	-	-	-	-	-27	-19	-13	-8.71	-3.42	5.57	12
Other Equity Adjustments	-	-	-	-	-	-	-	0.00	-0.29	-0.66	-0.56

This table presents FitLife Brands' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	44	55	57	59	62	63	110	104
Total Current Assets	20	15	17	18	22	22	37	32
Cash & Equivalents	7.34	2.54	3.68	4.66	5.94	1.53	3.51	1.19
Accounts Receivable	1.43	2.27	2.50	2.01	2.69	2.49	9.64	7.78
Inventories, net	7.72	8.87	9.78	10	12	12	22	22
Prepaid Expenses	0.79	0.45	0.91	0.94	0.94	1.38	2.02	1.14
Plant, Property, & Equipment, net	0.20	0.12	0.11	0.09	0.09	0.08	0.14	0.11
Total Noncurrent Assets	24	40	40	40	40	41	72	73
Goodwill	13	13	13	13	13	13	19	19
Intangible Assets	7.75	26	26	26	26	26	52	51
Noncurrent Deferred & Refundable Income Taxes	1.21	0.61	0.68	0.52	0.69	0.82	0.57	1.22
Other Noncurrent Operating Assets	1.97	0.10	0.07	0.43	0.39	0.37	0.87	0.74
Total Liabilities & Shareholders' Equity	44	55	57	59	62	63	110	104
Total Liabilities	19	26	25	24	23	22	68	59
Total Current Liabilities	7.39	12	12	12	13	13	33	21
Short-Term Debt	2.50	4.50	4.50	4.50	4.50	4.50	14	6.09
Accounts Payable	2.38	3.98	4.31	4.08	5.28	4.94	9.15	6.45
Accrued Expenses	1.83	1.40	1.08	0.96	1.12	1.41	6.80	5.60
Customer Deposits	0.59	0.52	0.53	0.57	0.57	0.52	0.86	0.83
Current Deferred & Payable Income Tax Liabilities	-	1.36	1.84	1.86	1.75	1.52	1.69	1.49
Other Current Liabilities	0.09	0.07	0.06	0.09	0.08	0.07	0.43	0.34
Total Noncurrent Liabilities	11	14	13	12	9.98	8.96	35	38
Long-Term Debt	8.75	12	11	9.66	7.44	6.32	32	36
Noncurrent Deferred & Payable Income Tax Liabilities	2.53	2.35	2.33	2.36	2.23	2.34	2.29	2.28
Other Noncurrent Operating Liabilities	0.06	0.03	0.03	0.35	0.31	0.30	0.42	0.26
Total Equity & Noncontrolling Interests	25	29	32	34	39	41	42	45
Total Preferred & Common Equity	25	29	32	34	39	41	42	45
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	25	29	32	34	39	41	42	45
Common Stock	30	31	31	31	32	32	32	32
Retained Earnings	-4.90	-1.26	1.37	3.50	7.59	9.33	10	14
Other Equity Adjustments	-0.05	-0.21	-0.46	-0.43	-0.63	-0.52	-0.60	-0.56

This table displays calculated financial ratios and metrics derived from FitLife Brands' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	10,358,222.00	10,450,965.00	10,623,522.00	11,084,545.00	933,305.00	1,060,644.00	1,125,690.00	4,543,957.00	4,589,641.00	-	9,391,072.00
DEI Adjusted Shares Outstanding	20,716,444.00	20,901,930.00	21,247,044.00	22,169,090.00	1,866,610.00	2,121,288.00	2,251,380.00	9,087,914.00	9,179,282.00	-	9,391,072.00
DEI Earnings Per Adjusted Shares Outstanding	-0.05	0.02	-0.46	-	2.73	4.16	2.40	0.49	0.58	-	0.67
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-10.16%	41.17%	-29.69%	-4.06%	0.00%	-42.23%	26.24%	3.19%	82.97%	22.33%	26.35%
EBITDA Growth	-137.99%	221.04%	-993.90%	108.23%	644.88%	-17.18%	42.32%	-8.16%	41.51%	62.24%	-13.66%
EBIT Growth	-158.84%	143.82%	-1,974.89%	107.11%	715.93%	-17.12%	41.08%	-8.49%	35.75%	70.16%	-24.11%
NOPAT Growth	-145.64%	161.91%	-1,426.88%	110.20%	677.97%	74.89%	-42.23%	-13.68%	31.65%	73.89%	-22.09%
Net Income Growth	-164.29%	134.21%	-2,751.88%	105.21%	0.00%	69.06%	-38.70%	-18.13%	19.58%	69.64%	-29.59%
EPS Growth	-165.00%	130.77%	-2,425.00%	104.30%	0.00%	-58.37%	-41.75%	-21.24%	19.58%	69.64%	-30.77%
Operating Cash Flow Growth	-263.00%	101.96%	1,282.63%	-122.51%	0.00%	153.03%	-21.69%	-7.81%	2.18%	127.73%	-22.59%
Free Cash Flow Firm Growth	-482.53%	105.78%	916.09%	-81.64%	207.68%	154.40%	-35.30%	3.04%	-952.43%	133.26%	-427.70%
Invested Capital Growth	133.86%	0.94%	-99.36%	-100.00%	0.00%	113.51%	24.34%	8.89%	456.61%	-1.09%	93.78%
Revenue Q/Q Growth	63.68%	13.09%	-12.57%	545.23%	0.00%	0.00%	3.35%	-5.98%	17.71%	2.73%	15.44%
EBITDA Q/Q Growth	-294.43%	229.03%	-799.68%	71.71%	0.00%	18,658.33%	0.60%	-10.90%	27.64%	3.61%	1.68%
EBIT Q/Q Growth	-694.40%	138.16%	-545.29%	123.27%	0.00%	0.00%	0.21%	-11.84%	21.42%	6.48%	-6.66%
NOPAT Q/Q Growth	-694.40%	153.92%	-545.29%	115.65%	0.00%	0.00%	-45.97%	-15.81%	25.73%	7.06%	1.87%
Net Income Q/Q Growth	-1,525.16%	128.87%	-591.17%	78.90%	0.00%	0.00%	-45.93%	-14.89%	23.48%	7.03%	-6.36%
EPS Q/Q Growth	-1,400.00%	125.00%	-675.00%	-174.19%	0.00%	0.00%	527.78%	-15.24%	23.48%	7.03%	-12.50%
Operating Cash Flow Q/Q Growth	-785.95%	103.05%	1,183.00%	316.10%	0.00%	42.60%	-17.74%	-34.27%	122.22%	-4.86%	-8.75%
Free Cash Flow Firm Q/Q Growth	-25,237.40%	106.34%	202.74%	0.00%	1,011.11%	1,114.08%	-16.38%	-40.18%	-84.83%	269.66%	-1.50%
Invested Capital Q/Q Growth	73.08%	-6.70%	-99.25%	-100.00%	-9.72%	125.73%	-3.12%	21.11%	60.17%	2.42%	2.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.01%	39.79%	28.60%	79.00%	41.71%	43.13%	44.80%	41.78%	40.67%	43.56%	38.61%
EBITDA Margin	-4.40%	3.78%	-48.00%	8.46%	14.05%	20.14%	22.71%	20.21%	15.63%	20.73%	14.12%
Operating Margin	-6.08%	1.87%	-50.30%	7.65%	13.03%	19.66%	22.32%	19.79%	14.33%	20.35%	12.35%
EBIT Margin	-6.08%	1.89%	-50.30%	7.65%	13.92%	19.97%	22.32%	19.79%	14.69%	20.43%	12.27%
Profit (Net Income) Margin	-6.00%	1.45%	-54.84%	5.96%	13.64%	39.91%	19.38%	15.38%	10.05%	13.94%	7.77%
Tax Burden Percent	98.74%	100.00%	107.59%	195.77%	99.73%	200.11%	80.65%	76.07%	75.62%	75.68%	76.87%
Interest Burden Percent	100.00%	77.09%	101.34%	159.27%	98.24%	99.86%	107.67%	102.12%	90.49%	90.14%	82.34%
Effective Tax Rate	0.00%	0.00%	0.00%	4.23%	0.27%	-100.11%	19.35%	23.93%	24.38%	24.32%	23.13%
Return on Invested Capital (ROIC)	-10.61%	4.67%	-122.49%	1,966.73%	354.43%	197.72%	74.77%	55.74%	21.44%	22.11%	11.79%
ROIC Less NNEP Spread (ROIC-NNEP)	15.00%	56.10%	453.54%	1,997.47%	167.76%	193.56%	69.88%	54.95%	4.33%	15.02%	6.31%
Return on Net Nonoperating Assets (RNNOA)	-2.18%	-1.10%	-48.08%	-1,855.11%	-14.48%	-79.63%	-37.74%	-32.88%	0.43%	6.34%	4.07%
Return on Equity (ROE)	-12.79%	3.57%	-170.57%	111.62%	339.95%	118.10%	37.03%	22.87%	21.87%	28.45%	15.86%
Cash Return on Invested Capital (CROIC)	-90.80%	3.73%	74.97%	2,166.73%	154.43%	125.31%	53.07%	47.24%	-117.64%	23.21%	-52.05%
Operating Return on Assets (OROA)	-7.88%	2.90%	-80.49%	19.03%	176.48%	38.97%	32.68%	24.15%	19.10%	23.13%	12.12%
Return on Assets (ROA)	-7.78%	2.24%	-87.77%	22.83%	172.90%	77.88%	28.38%	18.76%	13.07%	15.78%	7.67%
Return on Common Equity (ROCE)	-12.79%	3.57%	-170.57%	223.25%	339.95%	118.10%	37.03%	22.87%	21.87%	28.45%	15.86%
Return on Equity Simple (ROE_SIMPLE)	-10.64%	3.49%	-1,070.29%	22.00%	169.98%	74.32%	31.19%	20.71%	19.59%	24.87%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.76	0.47	-6.27	0.64	4.97	8.70	5.02	4.34	5.71	9.93	7.74
NOPAT Margin	-4.25%	1.87%	-35.21%	7.49%	12.99%	39.33%	18.00%	15.06%	10.83%	15.40%	9.50%
Net Nonoperating Expense Percent (NNEP)	-25.61%	-51.43%	-576.03%	-30.74%	186.67%	4.17%	4.89%	0.79%	17.11%	7.09%	5.48%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	12.14%	20.19%	8.77%
Cost of Revenue to Revenue	64.99%	60.21%	71.40%	121.00%	58.29%	56.87%	55.20%	58.22%	59.33%	56.44%	61.39%
SG&A Expenses to Revenue	23.10%	19.76%	23.53%	39.04%	15.93%	13.78%	22.27%	20.87%	14.96%	15.47%	17.23%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	41.09%	37.92%	78.94%	71.35%	28.68%	23.48%	22.48%	21.99%	26.34%	23.21%	26.26%
Earnings before Interest and Taxes (EBIT)	-1.09	0.48	-8.95	0.65	5.33	4.42	6.23	5.70	7.74	13	9.99
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-0.79	0.96	-8.54	0.72	5.38	4.45	6.34	5.82	8.24	13	11
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.47	4.47	3.72
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.33	0.00	0.00	0.00	0.00	1.78	2.50	1.99
Price to Earnings (P/E)	0.00	0.00	0.00	13.81	0.00	0.00	0.00	0.00	17.69	17.96	25.66
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	7.24%	0.00%	0.00%	0.00%	0.00%	5.65%	5.57%	3.90%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.48	3.80	2.37
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.67	0.00	0.00	0.00	0.00	2.12	2.63	2.52
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	15.79	0.00	0.00	0.00	0.00	13.57	12.71	17.85
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	17.46	0.00	0.00	0.00	0.00	14.45	12.90	20.53
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	17.84	0.00	0.00	0.00	0.00	19.58	17.11	26.53
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	43.27	0.00	0.00	0.00	0.00	26.49	17.68	27.59
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	7.93	0.00	0.00	0.00	0.00	0.00	16.30	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.15	0.09	0.46	0.00	0.00	0.04	0.00	0.00	0.74	0.36	1.02
Long-Term Debt to Equity	0.09	0.04	0.00	0.00	0.00	0.04	0.00	0.00	0.57	0.24	0.88
Financial Leverage	-0.15	-0.02	-0.11	-1.86	-0.09	-0.41	-0.54	-0.60	0.10	0.42	0.64
Leverage Ratio	1.64	1.60	1.94	15.05	1.97	1.52	1.31	1.22	1.67	1.80	2.07
Compound Leverage Factor	1.64	1.23	1.97	11.99	1.93	1.51	1.41	1.24	1.51	1.63	1.70
Debt to Total Capital	12.87%	8.09%	31.27%	0.00%	0.00%	3.67%	0.00%	0.00%	42.53%	26.54%	50.51%
Short-Term Debt to Total Capital	4.99%	4.87%	31.27%	0.00%	0.00%	0.00%	0.00%	0.00%	9.57%	9.15%	6.91%
Long-Term Debt to Total Capital	7.88%	3.22%	0.00%	0.00%	0.00%	3.67%	0.00%	0.00%	32.97%	17.39%	43.60%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	87.13%	91.91%	68.73%	0.00%	100.00%	96.33%	100.00%	100.00%	57.47%	73.46%	49.49%
Debt to EBITDA	-1.89	0.97	-0.05	0.00	0.00	0.10	0.00	0.00	2.43	0.98	3.87
Net Debt to EBITDA	0.05	-0.38	0.10	0.33	0.00	-1.32	0.00	0.00	2.20	0.64	3.73
Long-Term Debt to EBITDA	-1.16	0.39	0.00	0.00	0.00	0.10	0.00	0.00	1.88	0.64	3.34
Debt to NOPAT	-1.96	1.96	-0.07	1.56	0.00	0.05	0.00	0.00	3.50	1.31	5.76
Net Debt to NOPAT	0.05	-0.78	0.14	0.00	0.00	-0.68	0.00	0.00	3.17	0.86	5.55
Long-Term Debt to NOPAT	-1.20	0.78	0.00	0.00	0.00	0.05	0.00	0.00	2.72	0.86	4.97
Altman Z-Score	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.41	6.44	2.92
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.46	1.77	1.06	0.00	1.96	2.84	4.36	5.43	1.42	1.60	1.53
Quick Ratio	0.65	0.88	0.54	0.00	0.72	1.97	2.67	3.27	0.31	0.54	0.48
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-6.53	0.38	3.84	0.70	2.17	5.51	3.57	3.67	-31	10	-34
Operating Cash Flow to CapEx	-19,133.65%	205.81%	360.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3,981.13%	96,100.00%	17.49%
Free Cash Flow to Firm to Interest Expense	0.00	3.45	0.00	10.59	23.05	0.00	0.00	0.00	-30.56	7.62	-18.33
Operating Cash Flow to Interest Expense	0.00	0.44	0.00	5.82	24.05	0.00	0.00	0.00	4.12	7.03	3.99
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.23	0.00	3.94	24.05	0.00	0.00	0.00	4.01	7.02	-18.84
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.30	1.54	1.60	7.66	12.68	1.95	1.46	1.22	1.30	1.13	0.99
Accounts Receivable Turnover	8.21	9.53	7.77	10.07	0.00	12.58	20.36	34.91	38.31	35.11	15.68
Inventory Turnover	3.29	3.57	3.83	0.00	0.00	3.65	3.07	2.15	3.44	3.61	3.09
Fixed Asset Turnover	155.99	127.27	76.23	0.00	0.00	188.98	332.30	496.60	575.96	608.20	802.54
Accounts Payable Turnover	5.58	6.15	5.56	3.69	0.00	4.78	5.03	5.71	10.00	9.93	9.11
Days Sales Outstanding (DSO)	44.48	38.29	47.00	0.00	0.00	29.01	17.93	10.45	9.53	10.39	23.28
Days Inventory Outstanding (DIO)	110.81	102.33	95.22	112.99	0.00	99.96	119.02	170.05	106.20	101.13	118.24
Days Payable Outstanding (DPO)	65.42	59.39	65.64	0.00	0.00	76.40	72.55	63.94	36.51	36.75	40.07
Cash Conversion Cycle (CCC)	89.86	81.22	76.58	0.00	0.00	52.57	64.39	116.57	79.22	74.78	101.46
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	10	10	0.07	0.00	2.81	5.99	7.45	8.11	45	45	87
Invested Capital Turnover	2.49	2.50	3.48	525.45	27.28	5.03	4.15	3.70	1.98	1.44	1.24
Increase / (Decrease) in Invested Capital	5.77	0.09	-10	-0.07	2.81	3.19	1.46	0.66	37	-0.49	42
Enterprise Value (EV)	0.00	0.00	0.00	5.58	0.00	0.00	0.00	0.00	112	170	205
Market Capitalization	0.00	0.00	0.00	5.58	0.00	0.00	0.00	0.00	94	161	162
Book Value per Share	$0.98	$1.01	$0.09	$0.00	$3.29	$11.20	$15.41	$4.71	$5.89	$7.86	$4.65
Tangible Book Value per Share	$0.31	$0.39	$0.06	$0.00	$3.05	$10.98	$14.92	$4.60	($2.74)	($0.68)	($2.90)
Total Capital	12	11	1.33	0.00	3.07	12	17	21	47	49	88
Total Debt	1.49	0.93	0.42	0.00	0.00	0.45	0.00	0.00	20	13	45
Total Long-Term Debt	0.91	0.37	0.00	0.00	0.00	0.45	0.00	0.00	16	8.55	38
Net Debt	-0.04	-0.37	-0.85	0.00	-0.27	-5.88	-9.90	-13	18	8.53	43
Capital Expenditures (CapEx)	0.01	0.02	0.19	-0.00	0.00	0.00	0.00	0.00	0.11	0.01	43
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2.05	2.72	-0.48	0.00	2.39	1.28	3.73	5.66	6.96	6.81	16
Debt-free Net Working Capital (DFNWC)	3.58	4.01	0.78	0.00	2.65	7.62	14	19	8.86	11	18
Net Working Capital (NWC)	3.00	3.46	0.37	0.00	2.65	7.62	14	19	4.36	6.83	11
Net Nonoperating Expense (NNE)	0.31	0.10	3.49	0.13	-0.25	-0.13	-0.39	-0.09	0.41	0.94	1.41
Net Nonoperating Obligations (NNO)	-0.04	-0.37	-0.85	0.00	-0.27	-5.88	-9.90	-13	18	8.53	43
Total Depreciation and Amortization (D&A)	0.30	0.48	0.41	0.07	0.05	0.04	0.11	0.12	0.50	0.20	1.51
Debt-free, Cash-free Net Working Capital to Revenue	11.43%	10.75%	-2.69%	24.96%	6.24%	5.78%	13.36%	19.64%	13.20%	10.57%	19.53%
Debt-free Net Working Capital to Revenue	19.98%	15.86%	4.40%	14.00%	6.93%	34.44%	48.82%	65.73%	16.80%	17.58%	21.55%
Net Working Capital to Revenue	16.75%	13.66%	2.07%	22.14%	6.93%	34.44%	48.82%	65.73%	8.27%	10.60%	14.07%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.13)	$0.04	($0.93)	$0.04	$0.00	$8.23	$0.00	$0.97	$0.59	$0.98	$0.68
Adjusted Weighted Average Basic Shares Outstanding	8.68M	10.43M	10.52M	10.94M	0.00	1.06M	0.00	4.55M	8.98M	9.20M	9.35M
Adjusted Diluted Earnings per Share	($0.13)	$0.03	($0.93)	$0.04	$0.00	$7.66	$0.00	$0.89	$0.54	$0.91	$0.63
Adjusted Weighted Average Diluted Shares Outstanding	8.68M	11.52M	10.52M	10.94M	0.00	1.14M	0.00	4.97M	9.81M	9.90M	9.98M
Adjusted Basic & Diluted Earnings per Share	($0.13)	$0.04	($0.93)	$0.04	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	11.12M	0.00	5.12M	0.00	4.45M	9.20M	9.22M	9.39M
Normalized Net Operating Profit after Tax (NOPAT)	-0.76	0.33	-2.12	0.64	4.97	3.04	5.02	4.53	6.94	10	9.33
Normalized NOPAT Margin	-4.25%	1.31%	-11.89%	7.49%	12.99%	13.76%	18.00%	15.74%	13.17%	15.70%	11.45%
Pre Tax Income Margin	-6.08%	1.45%	-50.97%	6.09%	13.68%	19.94%	24.03%	20.21%	13.29%	18.41%	10.10%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	4.36	0.00	4.91	56.68	0.00	0.00	0.00	7.55	9.63	5.36
NOPAT to Interest Expense	0.00	4.32	0.00	14.42	52.90	0.00	0.00	0.00	5.57	7.26	4.15
EBIT Less CapEx to Interest Expense	0.00	4.15	0.00	14.82	56.68	0.00	0.00	0.00	7.45	9.63	-17.47
NOPAT Less CapEx to Interest Expense	0.00	4.10	0.00	9.67	52.90	0.00	0.00	0.00	5.47	7.26	-18.68
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	1.21%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	42.63%	0.00%	0.00%	30.40%	1.94%	8.21%	17.59%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from FitLife Brands' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	4,446,161.00	4,589,641.00	4,598,241.00	4,598,241.00	4,598,241.00	-	9,218,528.00	9,391,072.00	9,391,072.00	9,391,072.00	9,391,072.00
DEI Adjusted Shares Outstanding	8,892,322.00	9,179,282.00	9,196,482.00	9,196,482.00	9,196,482.00	-	9,218,528.00	9,391,072.00	9,391,072.00	9,391,072.00	9,391,072.00
DEI Earnings Per Adjusted Shares Outstanding	0.19	0.16	0.23	0.29	0.23	-	0.22	0.19	0.10	0.17	0.18
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	67.21%	147.63%	54.12%	14.70%	14.93%	12.88%	-3.70%	-4.74%	46.99%	72.58%	58.92%
EBITDA Growth	46.38%	228.04%	446.65%	32.45%	43.87%	18.79%	-12.83%	-30.98%	-13.95%	8.34%	15.32%
EBIT Growth	46.66%	184.71%	471.24%	32.36%	41.73%	38.07%	-13.00%	-30.72%	-27.82%	-24.54%	4.94%
NOPAT Growth	65.71%	264.33%	1,252.75%	47.33%	18.77%	41.49%	-10.81%	-35.70%	-47.78%	19.64%	2.18%
Net Income Growth	39.02%	212.90%	1,284.62%	33.81%	25.35%	39.86%	-6.57%	-33.52%	-56.68%	-20.77%	-14.77%
EPS Growth	45.83%	212.90%	1,284.62%	33.81%	25.35%	39.86%	-4.76%	-33.33%	-57.14%	-21.74%	-15.00%
Operating Cash Flow Growth	-62.74%	265.86%	2,070.69%	0.51%	109.30%	-33.91%	-53.77%	-23.89%	79.38%	-74.50%	6.70%
Free Cash Flow Firm Growth	-996.02%	-15,611.11%	14.16%	8.15%	33.01%	107.73%	98.76%	66.47%	-205.95%	-1,529.93%	-20,983.86%
Invested Capital Growth	320.89%	456.61%	68.70%	67.62%	54.69%	-1.09%	5.60%	15.57%	94.57%	93.78%	91.30%
Revenue Q/Q Growth	-5.81%	-4.33%	24.43%	2.30%	-5.63%	-6.03%	6.15%	1.20%	45.63%	10.33%	-2.26%
EBITDA Q/Q Growth	-19.34%	8.68%	37.98%	9.50%	-12.38%	-8.65%	1.26%	-13.31%	9.24%	9.91%	10.79%
EBIT Q/Q Growth	-18.82%	-6.90%	60.46%	9.15%	-13.08%	-9.30%	1.10%	-13.07%	-9.44%	-5.19%	40.60%
NOPAT Q/Q Growth	0.72%	-19.16%	54.82%	16.88%	-18.80%	-3.70%	-2.41%	-15.74%	-34.05%	120.62%	-16.65%
Net Income Q/Q Growth	-13.65%	-12.74%	45.95%	21.67%	-19.10%	-2.63%	-2.51%	-13.43%	-47.28%	78.07%	4.88%
EPS Q/Q Growth	-12.50%	-12.74%	45.95%	21.67%	-19.10%	-2.63%	-13.04%	-10.00%	-50.00%	100.00%	-5.56%
Operating Cash Flow Q/Q Growth	-37.39%	48.06%	247.79%	-68.82%	30.38%	-53.25%	143.26%	-48.67%	207.28%	-93.36%	918.03%
Free Cash Flow Firm Q/Q Growth	-22.57%	-81.56%	58.14%	1.41%	10.60%	120.95%	-106.70%	-2,571.93%	-715.61%	2.07%	1.21%
Invested Capital Q/Q Growth	8.86%	60.17%	-5.91%	2.16%	0.47%	2.42%	0.46%	11.80%	69.15%	2.00%	-0.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	40.97%	40.32%	44.03%	44.77%	43.82%	41.38%	43.14%	42.81%	37.20%	34.50%	37.58%
EBITDA Margin	16.41%	18.65%	20.68%	22.13%	20.55%	19.62%	18.72%	16.04%	12.03%	11.98%	13.58%
Operating Margin	17.77%	13.71%	20.43%	21.71%	19.92%	19.19%	18.56%	15.61%	9.87%	8.75%	12.09%
EBIT Margin	16.26%	15.82%	20.40%	21.77%	20.05%	19.35%	18.43%	15.83%	9.84%	8.46%	12.17%
Profit (Net Income) Margin	12.20%	11.13%	13.05%	15.52%	13.31%	13.79%	12.66%	10.83%	3.92%	6.33%	6.79%
Tax Burden Percent	79.62%	87.21%	72.80%	78.28%	73.41%	78.08%	74.22%	73.47%	52.63%	118.67%	73.29%
Interest Burden Percent	94.25%	80.66%	87.89%	91.10%	90.42%	91.26%	92.58%	93.15%	75.69%	63.05%	76.15%
Effective Tax Rate	20.38%	12.79%	27.20%	21.72%	26.59%	21.92%	25.78%	26.53%	47.37%	-18.67%	26.72%
Return on Invested Capital (ROIC)	36.31%	23.66%	25.72%	29.76%	25.56%	21.51%	20.14%	15.46%	5.71%	12.90%	12.32%
ROIC Less NNEP Spread (ROIC-NNEP)	40.83%	19.11%	22.11%	26.10%	22.17%	20.17%	18.28%	14.47%	4.57%	8.81%	10.06%
Return on Net Nonoperating Assets (RNNOA)	-10.44%	1.91%	7.23%	6.36%	4.62%	8.51%	5.10%	4.13%	3.15%	5.68%	5.53%
Return on Equity (ROE)	25.87%	25.57%	32.96%	36.13%	30.18%	30.02%	25.24%	19.59%	8.85%	18.58%	17.85%
Cash Return on Invested Capital (CROIC)	-97.17%	-117.64%	-27.57%	-24.83%	-17.11%	23.21%	16.67%	4.01%	-52.39%	-52.05%	-50.75%
Operating Return on Assets (OROA)	20.52%	20.57%	24.57%	25.66%	24.53%	21.91%	20.00%	16.61%	8.24%	8.36%	13.28%
Return on Assets (ROA)	15.40%	14.47%	15.72%	18.30%	16.28%	15.61%	13.74%	11.37%	3.28%	6.26%	7.41%
Return on Common Equity (ROCE)	25.87%	25.57%	32.96%	36.13%	30.18%	30.02%	25.24%	19.59%	8.85%	18.58%	17.85%
Return on Equity Simple (ROE_SIMPLE)	16.99%	0.00%	24.85%	0.00%	0.00%	0.00%	22.72%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	1.97	1.59	2.46	2.88	2.34	2.25	2.20	1.85	1.22	2.69	2.24
NOPAT Margin	14.15%	11.95%	14.87%	16.99%	14.62%	14.98%	13.78%	11.47%	5.19%	10.39%	8.86%
Net Nonoperating Expense Percent (NNEP)	-4.52%	4.55%	3.61%	3.67%	3.39%	1.35%	1.86%	0.99%	1.14%	4.09%	2.26%
Return On Investment Capital (ROIC_SIMPLE)	-	3.38%	5.38%	6.10%	4.83%	4.57%	4.32%	3.58%	1.38%	3.05%	2.58%
Cost of Revenue to Revenue	59.03%	59.68%	55.97%	55.23%	56.18%	58.62%	56.87%	57.19%	62.80%	65.50%	62.42%
SG&A Expenses to Revenue	13.65%	13.97%	15.16%	14.93%	16.56%	7.08%	15.76%	15.41%	17.48%	19.04%	19.60%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.21%	26.62%	23.60%	22.92%	23.90%	22.19%	24.57%	27.20%	27.33%	25.75%	25.49%
Earnings before Interest and Taxes (EBIT)	2.26	2.10	3.38	3.69	3.20	2.91	2.94	2.55	2.31	2.19	3.08
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2.28	2.48	3.42	3.75	3.28	2.95	2.98	2.59	2.83	3.11	3.44
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	3.47	4.08	5.17	4.76	4.47	3.09	3.17	4.75	3.72	3.13
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	85.44	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	1.78	2.05	2.72	2.59	2.50	1.88	2.06	2.82	1.99	1.56
Price to Earnings (P/E)	0.00	17.69	16.41	20.70	19.37	17.96	13.58	16.29	29.43	25.66	23.54
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	5.65%	6.10%	4.83%	5.16%	5.57%	7.36%	6.14%	3.40%	3.90%	4.25%
Enterprise Value to Invested Capital (EV/IC)	0.00	2.48	3.13	4.06	3.94	3.80	2.81	2.77	2.85	2.37	2.12
Enterprise Value to Revenue (EV/Rev)	0.00	2.12	2.27	2.91	2.74	2.63	1.97	2.20	3.43	2.52	2.01
Enterprise Value to EBITDA (EV/EBITDA)	0.00	13.57	12.04	14.76	13.30	12.71	9.75	11.81	21.38	17.85	15.26
Enterprise Value to EBIT (EV/EBIT)	0.00	14.45	12.63	15.44	13.91	12.90	9.90	11.98	22.58	20.53	17.98
Enterprise Value to NOPAT (EV/NOPAT)	0.00	19.58	16.67	19.81	18.55	17.11	13.05	16.10	31.84	26.53	23.38
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	26.49	14.72	19.53	17.03	17.68	18.26	21.29	29.66	27.59	24.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	16.30	17.32	74.12	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.45	0.74	0.56	0.48	0.41	0.36	0.31	0.26	1.11	1.02	0.92
Long-Term Debt to Equity	0.35	0.57	0.40	0.34	0.28	0.24	0.19	0.15	0.77	0.88	0.78
Financial Leverage	-0.26	0.10	0.33	0.24	0.21	0.42	0.28	0.29	0.69	0.64	0.55
Leverage Ratio	1.51	1.67	1.91	1.85	1.73	1.80	1.72	1.65	2.22	2.07	1.97
Compound Leverage Factor	1.43	1.35	1.67	1.68	1.56	1.65	1.60	1.54	1.68	1.30	1.50
Debt to Total Capital	30.82%	42.53%	35.82%	32.41%	29.31%	26.54%	23.47%	20.91%	52.58%	50.51%	47.84%
Short-Term Debt to Total Capital	6.85%	9.57%	9.83%	9.55%	9.31%	9.15%	8.85%	8.70%	15.95%	6.91%	7.00%
Long-Term Debt to Total Capital	23.97%	32.97%	25.99%	22.87%	20.00%	17.39%	14.62%	12.22%	36.63%	43.60%	40.84%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	69.18%	57.47%	64.18%	67.59%	70.69%	73.46%	76.53%	79.09%	47.42%	49.49%	52.16%
Debt to EBITDA	1.72	2.43	1.49	1.28	1.10	0.98	0.92	0.92	4.11	3.87	3.49
Net Debt to EBITDA	0.45	2.20	1.19	0.97	0.73	0.64	0.46	0.78	3.80	3.73	3.39
Long-Term Debt to EBITDA	1.34	1.88	1.08	0.90	0.75	0.64	0.58	0.54	2.86	3.34	2.97
Debt to NOPAT	2.48	3.50	2.06	1.72	1.53	1.31	1.24	1.25	6.12	5.76	5.34
Net Debt to NOPAT	0.65	3.17	1.64	1.30	1.02	0.86	0.62	1.07	5.66	5.55	5.18
Long-Term Debt to NOPAT	1.93	2.72	1.49	1.21	1.04	0.86	0.77	0.73	4.26	4.97	4.56
Altman Z-Score	0.00	3.07	4.04	5.29	5.45	5.86	4.61	5.07	2.64	2.67	2.72
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.64	1.42	1.27	1.38	1.50	1.60	1.64	1.71	1.13	1.53	1.52
Quick Ratio	1.19	0.31	0.41	0.50	0.55	0.54	0.65	0.31	0.40	0.48	0.43
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-20	-35	-15	-15	-13	2.74	-0.18	-4.91	-40	-39	-39
Operating Cash Flow to CapEx	16,300.00%	3,147.83%	50,360.00%	0.00%	0.00%	0.00%	9,700.00%	23.88%	9.79%	4,880.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-78.41	-83.01	-35.84	-42.41	-40.12	9.72	-0.75	-21.81	-68.99	-48.14	-52.67
Operating Cash Flow to Interest Expense	3.93	3.39	12.16	4.55	6.28	3.39	9.54	5.31	6.33	0.30	3.38
Operating Cash Flow Less CapEx to Interest Expense	3.90	3.28	12.14	4.55	6.28	3.39	9.44	-16.93	-58.34	0.29	3.38
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.26	1.30	1.20	1.18	1.22	1.13	1.09	1.05	0.84	0.99	1.09
Accounts Receivable Turnover	30.22	38.31	27.13	29.80	36.53	35.11	25.74	25.29	12.12	15.68	17.35
Inventory Turnover	3.47	3.44	3.87	3.67	3.93	3.61	3.45	3.35	2.57	3.09	3.37
Fixed Asset Turnover	355.33	575.96	489.63	452.84	432.80	608.20	608.15	674.36	624.43	802.54	931.76
Accounts Payable Turnover	8.36	10.00	7.72	8.82	11.00	9.93	7.82	7.80	6.33	9.11	9.68
Days Sales Outstanding (DSO)	12.08	9.53	13.46	12.25	9.99	10.39	14.18	14.43	30.13	23.28	21.03
Days Inventory Outstanding (DIO)	105.33	106.20	94.24	99.39	92.96	101.13	105.90	108.81	142.20	118.24	108.24
Days Payable Outstanding (DPO)	43.68	36.51	47.27	41.38	33.17	36.75	46.66	46.81	57.70	40.07	37.71
Cash Conversion Cycle (CCC)	73.73	79.22	60.42	70.26	69.78	74.78	73.42	76.44	114.63	101.46	91.57
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	28	45	42	43	44	45	45	50	85	87	86
Invested Capital Turnover	2.57	1.98	1.73	1.75	1.75	1.44	1.46	1.35	1.10	1.24	1.39
Increase / (Decrease) in Invested Capital	21	37	17	18	15	-0.49	2.38	6.76	41	42	41
Enterprise Value (EV)	0.00	112	133	176	172	170	126	139	242	205	182
Market Capitalization	0.00	94	120	165	163	161	120	130	199	162	142
Book Value per Share	$5.68	$5.89	$6.39	$6.93	$7.43	$7.86	$4.22	$4.36	$4.46	$4.65	$4.83
Tangible Book Value per Share	$0.94	($2.74)	($2.24)	($1.64)	($1.15)	($0.68)	($0.04)	$0.16	($3.10)	($2.90)	($2.68)
Total Capital	36	47	46	47	48	49	51	52	88	88	87
Total Debt	11	20	16	15	14	13	12	11	46	45	42
Total Long-Term Debt	8.75	16	12	11	9.66	8.55	7.44	6.32	32	38	36
Net Debt	2.94	18	13	12	9.44	8.53	5.94	9.24	43	43	40
Capital Expenditures (CapEx)	0.01	0.05	0.01	0.00	0.00	0.00	0.02	5.01	38	0.01	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	6.33	6.96	4.37	5.48	5.82	6.81	6.97	12	15	16	16
Debt-free Net Working Capital (DFNWC)	15	8.86	7.66	9.21	11	11	13	14	18	18	17
Net Working Capital (NWC)	12	4.36	3.16	4.71	6.04	6.83	8.46	9.21	4.38	11	11
Net Nonoperating Expense (NNE)	0.27	0.11	0.30	0.25	0.21	0.18	0.18	0.10	0.30	1.05	0.52
Net Nonoperating Obligations (NNO)	2.94	18	13	12	9.44	8.53	5.94	9.24	43	43	40
Total Depreciation and Amortization (D&A)	0.02	0.38	0.05	0.06	0.08	0.04	0.05	0.03	0.51	0.91	0.36
Debt-free, Cash-free Net Working Capital to Revenue	14.13%	13.20%	7.48%	9.02%	9.28%	10.57%	10.91%	19.23%	21.20%	19.53%	17.31%
Debt-free Net Working Capital to Revenue	32.70%	16.80%	13.10%	15.18%	16.80%	17.58%	20.30%	21.74%	26.17%	21.55%	18.63%
Net Working Capital to Revenue	27.11%	8.27%	5.41%	7.76%	9.63%	10.60%	13.25%	14.61%	6.20%	14.07%	11.92%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.38	$0.08	$0.24	$0.29	$0.23	$0.12	$0.22	$0.19	$0.10	$0.18	$0.18
Adjusted Weighted Average Basic Shares Outstanding	4.45M	17.96M	9.20M	9.20M	9.20M	18.39M	9.21M	9.39M	9.39M	9.35M	9.39M
Adjusted Diluted Earnings per Share	$0.35	$0.08	$0.22	$0.27	$0.22	$0.12	$0.20	$0.18	$0.09	$0.18	$0.17
Adjusted Weighted Average Diluted Shares Outstanding	4.89M	19.62M	10.06M	9.90M	9.93M	19.80M	9.93M	9.96M	10.00M	9.98M	9.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.08	$0.00	$0.00	$0.00	$0.12	$0.00	$0.00	$0.00	$0.18	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	4.59M	9.20M	9.20M	9.20M	9.20M	18.44M	9.39M	9.39M	9.39M	9.39M	9.39M
Normalized Net Operating Profit after Tax (NOPAT)	1.99	1.68	2.56	2.88	2.38	2.28	2.44	2.36	1.65	1.75	2.24
Normalized NOPAT Margin	14.33%	12.66%	15.46%	16.99%	14.89%	15.18%	15.32%	14.64%	7.03%	6.74%	8.86%
Pre Tax Income Margin	15.32%	12.76%	17.93%	19.83%	18.13%	17.66%	17.06%	14.75%	7.45%	5.33%	9.27%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.08	4.93	8.15	10.68	9.83	10.30	12.04	11.35	3.99	2.69	4.19
NOPAT to Interest Expense	7.90	3.72	5.95	8.34	7.17	7.98	9.00	8.22	2.10	3.31	3.05
EBIT Less CapEx to Interest Expense	9.05	4.82	8.13	10.68	9.83	10.30	11.94	-10.90	-60.68	2.69	4.19
NOPAT Less CapEx to Interest Expense	7.87	3.62	5.92	8.34	7.17	7.98	8.90	-14.02	-62.57	3.30	3.05
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

FitLife Brands (NASDAQ: FTLF) showed a much stronger start to 2026 on the income statement, but the balance sheet still reflects meaningful leverage and a heavy reliance on acquired intangible assets. Over the last several years, the company has grown revenue, improved operating profitability, and generated solid operating cash flow in several quarters. However, debt remains elevated and cash fell sharply from year-end 2025 into Q1 2026 after debt repayment.

Revenue growth resumed in Q1 2026. Sales rose to $25.3 million from $23.5 million in Q3 2025 and $15.9 million in Q1 2025, showing continued top-line expansion versus both prior-year and recent quarter levels.
Gross profit improved meaningfully. Q1 2026 gross profit was $9.5 million, up from $8.7 million in Q3 2025 and $6.9 million in Q1 2025, suggesting better scale and/or product mix.
Operating income strengthened. Q1 2026 operating income reached $3.1 million, compared with $2.3 million in Q3 2025 and $3.0 million in Q1 2025.
Net income remained positive. The company earned $1.7 million in Q1 2026, which continues a multi-quarter pattern of profitability.
Operating cash flow was solid in Q1 2026. FitLife generated $2.5 million of cash from operations, well ahead of net income, indicating decent cash conversion.
Debt has come down from 2025 levels. Short-term debt dropped to $6.1 million from $14.1 million at Q3 2025, while long-term debt declined to $35.5 million from $32.4 million, reflecting active balance-sheet management across the period.
Equity increased year over year. Total common equity rose to $45.4 million in Q1 2026 from $34.2 million in Q3 2025 and $29.4 million in Q1 2024, supported by retained earnings growth.
Free cash flow appears lumpy. Capex was minimal in some quarters, but Q3 2025 included a very large investing outflow tied to purchases of property, plant and equipment, which makes cash generation look less consistent than operating income alone would suggest.
Share count has been fairly stable recently. Basic weighted-average shares were 9.39 million in Q1 2026 versus 9.39 million in Q1 2025, so dilution has not been a major issue in the most recent quarter.
Cash fell sharply in Q1 2026. Cash and equivalents declined to $1.2 million from $3.5 million in Q3 2025 and $5.9 million in Q1 2025, leaving the company with a smaller liquidity cushion.
Leverage remains significant. Even after recent debt repayment, total liabilities were $58.9 million in Q1 2026 versus $45.4 million of equity, so the balance sheet still carries meaningful financial obligations.
Intangible assets dominate the asset base. Goodwill and intangible assets totaled about $70.6 million in Q1 2026, or roughly two-thirds of total assets, which leaves the balance sheet exposed to impairment risk if performance weakens.
Interest expense is still a drag. Q1 2026 interest expense was $735,000, a sizable burden relative to pre-tax income of $2.3 million.

Bottom line: FitLife Brands is showing encouraging operating momentum, especially in revenue, margins, and cash from operations. But investors should keep an eye on leverage, liquidity, and the company’s large intangible asset base, all of which make the story more vulnerable if growth slows or cash generation weakens.

07/14/26 07:23 AM ETAI Generated. May Contain Errors.

FitLife Brands Financials - Frequently Asked Questions

According to the most recent income statement we have on file, FitLife Brands' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

FitLife Brands' net income appears to be on an upward trend, with a most recent value of $6.33 million in 2025, rising from $1.67 million in 2014. The previous period was $8.98 million in 2024. See where experts think FitLife Brands is headed by visiting FitLife Brands' forecast page.

FitLife Brands' total operating income in 2025 was $10.06 million, based on the following breakdown:

Total Gross Profit: $31.45 million
Total Operating Expenses: $21.39 million

Over the last 10 years, FitLife Brands' total revenue changed from $19.96 million in 2014 to $81.46 million in 2025, a change of 308.1%.

FitLife Brands' total liabilities were at $62.68 million at the end of 2025, a 179.8% increase from 2024, and a 1,748.9% increase since 2014.

In the past 10 years, FitLife Brands' cash and equivalents has ranged from $265 thousand in 2019 to $13.28 million in 2022, and is currently $1.65 million as of their latest financial filing in 2025.

Over the last 10 years, FitLife Brands' book value per share changed from 0.98 in 2015 to 4.65 in 2025, a change of 376.1%.

Related Companies

Financial statements for NASDAQ:FTLF last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FitLife Brands (FTLF) Financials

Financials Breakdown Chart

Key Financial Trends

FitLife Brands Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

FitLife Brands (FTLF) Financials

Annual Income Statements for FitLife Brands

Quarterly Income Statements for FitLife Brands

Annual Cash Flow Statements for FitLife Brands

Quarterly Cash Flow Statements for FitLife Brands

Annual Balance Sheets for FitLife Brands

Quarterly Balance Sheets for FitLife Brands

Annual Metrics And Ratios for FitLife Brands

Quarterly Metrics And Ratios for FitLife Brands

Financials Breakdown Chart

Key Financial Trends

FitLife Brands Financials - Frequently Asked Questions

When does FitLife Brands' financial year end?

How has FitLife Brands' net income changed over the last 10 years?

What is FitLife Brands' operating income?

How has FitLife Brands' revenue changed over the last 10 years?

How much debt does FitLife Brands have?

How much cash does FitLife Brands have?

How has FitLife Brands' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools